Literature DB >> 12669237

Changes in matrix metalloproteinases and their endogenous inhibitors during tumor progression in the uterine cervix.

S Asha Nair1, D Karunagaran, M B Nair, P R Sudhakaran.   

Abstract

PURPOSE: To study the role of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in cervical tumorigenesis, we analyzed 70 cervical tissue specimens that included 15 low-grade squamous intraepithelial lesions (SILs), 20 high-grade SILs, 25 squamous cell carcinomas (SCCs) and 10 specimens of normal cervical tissue.
METHODS: The gelatinolytic activity of MMP-9 and MMP-2 was determined by zymographic analysis. The expression of MMP-9 and MMP-2 and TIMP-1 and TIMP-2 was determined by immunohistochemistry.
RESULTS: All the samples had 72/66 kDa gelatinase activity; 92 kDa gelatinase activity was detected only in high-grade SILs and SCCs. Immunohistochemical analysis showed weak positivity for MMP-2 in normal cervical epithelium and low-grade SILs. However, high-grade SILs and SCCs showed intense cellular and stromal reactivity for MMP-2 and MMP-9. For TIMP-1 and TIMP-2, normal cervical epithelium and low-grade SILs showed intense immunostaining, >50% of high-grade SILs showed positivity, and 95% of SCCs showed intense stromal and cellular reactivity.
CONCLUSIONS: Increase in the relative activity of these gelatinases and enhanced immunostaining for MMPs and TIMPs with tumor progression suggest that they may play a crucial role in cervical cancer progression. A significant association between stage of the lesion and expression of MMPs and TIMPs ( P<0.01) was found. Immunohistochemical studies indicate that these MMPs may be of basal cell origin in cervical tissue, although the mechanism of their upregulation is not clearly understood.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12669237     DOI: 10.1007/s00432-002-0411-9

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  31 in total

1.  The basement membrane and tumor progression in the uterine cervix.

Authors:  S A Nair; M B Nair; P G Jayaprakash; T N Rajalekshmy; M K Nair; M R Pillai
Journal:  Gen Diagn Pathol       Date:  1997-06

2.  Modulation of neutral matrix metalloproteinases of involuting rat mammary gland by different cations and glycosaminoglycans.

Authors:  M Ambili; P R Sudhakaran
Journal:  J Cell Biochem       Date:  1999-05-01       Impact factor: 4.429

3.  Augmentation of type IV collagenase, laminin receptor, and Ki67 proliferation antigen associated with human colon, gastric, and breast carcinoma progression.

Authors:  A D'Errico; S Garbisa; L A Liotta; V Castronovo; W G Stetler-Stevenson; W F Grigioni
Journal:  Mod Pathol       Date:  1991-03       Impact factor: 7.842

4.  Distribution of basement membrane antigens in the uterine cervical adenocarcinomas: an immunohistochemical study.

Authors:  N Toki; T Kaku; N Tsukamoto; M Matsumura; T Saito; T Kamura; T Matsuyama; H Nakano
Journal:  Gynecol Oncol       Date:  1990-07       Impact factor: 5.482

5.  Expression of matrix metalloproteinase-9 in squamous cell carcinoma of the uterine cervix-clinicopathologic study using immunohistochemistry and mRNA in situ hybridization.

Authors:  B Davidson; I Goldberg; J Kopolovic; L Lerner-Geva; W H Gotlieb; B Weis; G Ben-Baruch; R Reich
Journal:  Gynecol Oncol       Date:  1999-03       Impact factor: 5.482

6.  Relationship between expression of matrix metalloproteinase-2 and matrix metalloproteinase-9 and invasion ability of cervical cancer cells.

Authors:  Yasuhito Kato; Tsuyoshi Yamashita; Mutsuo Ishikawa
Journal:  Oncol Rep       Date:  2002 May-Jun       Impact factor: 3.906

7.  Anti-invasive effect of MMI-166, a new selective matrix metalloproteinase inhibitor, in cervical carcinoma cell lines.

Authors:  Masahiro Iwasaki; Akira Nishikawa; Takashi Fujimoto; Noriyuki Akutagawa; Kengo Manase; Toshiaki Endo; Koichi Yoshida; Ryuji Maekawa; Takayuki Yoshioka; Ryuichi Kudo
Journal:  Gynecol Oncol       Date:  2002-04       Impact factor: 5.482

Review 8.  Tissue inhibitor of metalloproteinases (TIMP, aka EPA): structure, control of expression and biological functions.

Authors:  D T Denhardt; B Feng; D R Edwards; E T Cocuzzi; U M Malyankar
Journal:  Pharmacol Ther       Date:  1993-09       Impact factor: 12.310

9.  Messenger RNA for two type IV collagenases is located in stromal cells in human colon cancer.

Authors:  C Pyke; E Ralfkiaer; K Tryggvason; K Danø
Journal:  Am J Pathol       Date:  1993-02       Impact factor: 4.307

10.  High level of MT-MMP expression is associated with invasiveness of cervical cancer cells.

Authors:  C Gilles; M Polette; J Piette; C Munaut; E W Thompson; P Birembaut; J M Foidart
Journal:  Int J Cancer       Date:  1996-01-17       Impact factor: 7.396

View more
  12 in total

1.  Proteolytic action of kallikrein-related peptidase 7 produces unique active matrix metalloproteinase-9 lacking the C-terminal hemopexin domains.

Authors:  Vishnu C Ramani; Gur P Kaushal; Randy S Haun
Journal:  Biochim Biophys Acta       Date:  2011-05-17

2.  An amino-bisphosphonate targets MMP-9-expressing macrophages and angiogenesis to impair cervical carcinogenesis.

Authors:  Enrico Giraudo; Masahiro Inoue; Douglas Hanahan
Journal:  J Clin Invest       Date:  2004-09       Impact factor: 14.808

3.  Histone deacetylase (HDAC) 10 suppresses cervical cancer metastasis through inhibition of matrix metalloproteinase (MMP) 2 and 9 expression.

Authors:  Chenlin Song; Songcheng Zhu; Chuanyue Wu; Jiuhong Kang
Journal:  J Biol Chem       Date:  2013-07-29       Impact factor: 5.157

4.  Modulation of u-PA, MMPs and their inhibitors by a novel nutrient mixture in human female cancer cell lines.

Authors:  M Waheed Roomi; Tatiana Kalinovsky; Matthias Rath; Aleksandra Niedzwiecki
Journal:  Oncol Rep       Date:  2012-06-20       Impact factor: 3.906

5.  HPV16 oncoproteins induce MMPs/RECK-TIMP-2 imbalance in primary keratinocytes: possible implications in cervical carcinogenesis.

Authors:  Laura Beatriz da Silva Cardeal; Enrique Boccardo; Lara Termini; Tatiana Rabachini; Maria Antonieta Andreoli; Celso di Loreto; Adhemar Longatto Filho; Luisa Lina Villa; Silvya Stuchi Maria-Engler
Journal:  PLoS One       Date:  2012-03-16       Impact factor: 3.240

6.  Kinetochore-associated protein 1 promotes the invasion and tumorigenicity of cervical cancer cells via matrix metalloproteinase-2 and matrix metalloproteinase-9.

Authors:  Caimei Wang; Yiyuan Wang; Congrong Liu; Xiaoyu Meng; Zhongxia Hang
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

7.  Effects of a nutrient mixture on immunohistochemical localization of cancer markers in human cervical cancer HeLa cell tumor xenografts in female nude mice.

Authors:  M W Roomi; T Kalinovsky; J Cha; N W Roomi; A Niedzwiecki; M Rath
Journal:  Exp Ther Med       Date:  2014-12-11       Impact factor: 2.447

8.  Kaempferia parviflora Extract Exhibits Anti-cancer Activity against HeLa Cervical Cancer Cells.

Authors:  Saranyapin Potikanond; Siriwoot Sookkhee; Mingkwan Na Takuathung; Pitchaya Mungkornasawakul; Nitwara Wikan; Duncan R Smith; Wutigri Nimlamool
Journal:  Front Pharmacol       Date:  2017-09-11       Impact factor: 5.810

9.  HPV16 oncoproteins promote cervical cancer invasiveness by upregulating specific matrix metalloproteinases.

Authors:  Jittranan Kaewprag; Wareerat Umnajvijit; Jarunya Ngamkham; Mathurose Ponglikitmongkol
Journal:  PLoS One       Date:  2013-08-13       Impact factor: 3.240

Review 10.  The Impact of Human Papilloma Viruses, Matrix Metallo-Proteinases and HIV Protease Inhibitors on the Onset and Progression of Uterine Cervix Epithelial Tumors: A Review of Preclinical and Clinical Studies.

Authors:  Giovanni Barillari; Paolo Monini; Cecilia Sgadari; Barbara Ensoli
Journal:  Int J Mol Sci       Date:  2018-05-09       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.